| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |